Malaysian Genomics Resource (0155) — Cash Flow-to-Debt Ratio
Malaysian Genomics Resource (0155) has a Cash Flow-to-Debt Ratio of 0.33x as of December 2025, meaning its operating cash flow of RM960.00K could theoretically repay 0% of its total liabilities (RM2.94 Million) in one year. See 0155 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Malaysian Genomics Resource Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Malaysian Genomics Resource across 11 annual periods. Also explore net asset growth rate of Malaysian Genomics Resource to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Malaysian Genomics Resource (2015–2025)
Year-by-year debt coverage analysis for Malaysian Genomics Resource. For market capitalisation and broader financial context, see Malaysian Genomics Resource (0155) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (MYR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | RM-744.97K | RM4.20 Million | ▲ +97.6% |
| 2024 | -7.44x | RM-24.97 Million | RM3.36 Million | ▼ -37.7% |
| 2023 | -5.40x | RM-22.07 Million | RM4.08 Million | ▼ -46069.1% |
| 2022 | 0.01x | RM56.92K | RM4.84 Million | ▲ +102.2% |
| 2021 | -0.54x | RM-2.64 Million | RM4.85 Million | ▼ -103.9% |
| 2020 | 14.09x | RM11.67 Million | RM827.98K | ▲ +43287.4% |
| 2019 | -0.03x | RM-687.64K | RM21.07 Million | ▲ +89.2% |
| 2018 | -0.30x | RM-6.34 Million | RM21.07 Million | ▼ -210.5% |
| 2017 | 0.27x | RM3.67 Million | RM13.49 Million | ▼ -84.7% |
| 2016 | 1.77x | RM3.68 Million | RM2.08 Million | ▲ +1722.3% |
| 2015 | 0.10x | RM395.83K | RM4.07 Million | — |